Novo Nordisk A/S
Novo Nordisk A/S (Denmark) has no DMF, CEP or site registration linked in our records. 7 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Novo Nordisk A/S: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/novo-nordisk-a-s
Overview
Novo Nordisk A/S is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. The company is also involved in the development and manufacture of treatments for obesity, hemophilia, growth disorders, and other serious chronic conditions.
Core services & business areas
Therapeutic areas
FDA compliance signals
7 FDA enforcement records linked to this company.
- 4832013-09-03
Procedures for sterile drug products
- 4832013-09-03
Complaint Handling Procedure
- 4832013-09-03
Complete test data included in records
- 4832013-09-03
Scientifically sound laboratory controls
- warning_letter2012-12-12
FDA Warning Letter (drug product)
- 4832011-09-08
Testing and release for distribution
- 4832011-09-08
Absence of Written Procedures
Is this Novo Nordisk A/S?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.